Dianthus Therapeutics, Inc.2025财年第一财季实现净利润-29.51百万美元，同比减少114.62%

市场透视2025-05-19

5月19日，Dianthus Therapeutics, Inc.（DNTH.US）公布财报，公告显示公司2025财年第一财季净利润为-29.51百万美元，同比减少114.62%；其中营业收入为1.16百万美元，同比增加32.72%，每股基本收益为-0.82美元。从资产负债表来看，Dianthus Therapeutics, Inc.（DNTH.US）总负债19.97百万美元，其中短期债务...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2536594430?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-19 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2536594430","market":"us","top_or_hot":-1,"title":"Dianthus Therapeutics, Inc.2025财年第一财季实现净利润-29.51百万美元，同比减少114.62%","media":"市场透视","content":"<div>\n<p>5月19日，Dianthus Therapeutics, Inc.（DNTH.US）公布财报，公告显示公司2025财年第一财季净利润为-29.51百万美元，同比减少114.62%；其中营业收入为1.16百万美元，同比增加32.72%，每股基本收益为-0.82美元。从资产负债表来看，Dianthus Therapeutics, Inc.（DNTH.US）总负债19.97百万美元，其中短期债务...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000246a6e3a77d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dianthus Therapeutics, Inc.2025财年第一财季实现净利润-29.51百万美元，同比减少114.62%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDianthus Therapeutics, Inc.2025财年第一财季实现净利润-29.51百万美元，同比减少114.62%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-19 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000246a6e3a77d&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>5月19日，Dianthus Therapeutics, Inc.（DNTH.US）公布财报，公告显示公司2025财年第一财季净利润为-29.51百万美元，同比减少114.62%；其中营业收入为1.16百万美元，同比增加32.72%，每股基本收益为-0.82美元。从资产负债表来看，Dianthus Therapeutics, Inc.（DNTH.US）总负债19.97百万美元，其中短期债务...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000246a6e3a77d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000246a6e3a77d&s=b","article_id":"2536594430","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000246a6e3a77d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2536594430","pubTimestamp":1747584051,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"5月19日，Dianthus Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-29.51百万美元，同比减少114.62%；其中营业收入为1.16百万美元，同比增加32.72%，每股基本收益为-0.82美元。从资产负债表来看，Dianthus Therapeutics, Inc.总负债19.97百万美元，其中短期债务226000.00美元，资产负债比为0.18，流动比率为0.16。机构评级：截至2025年5月19日，当前有10家机构对Dianthus Therapeutics, Inc.目标价做出预测，其中目标均价为51.40美元，其中最低目标价为34.00美元，最高目标价为84.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","DNTH":"Dianthus Therapeutics Inc."},"translate_title":"Dianthus Therapeutics, Inc. achieved net profit of-29.51 million in the first fiscal quarter of fiscal year 2025, a year-on-year decrease of 114.62%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"DNTH":0.9},"content_text":"5月19日，Dianthus Therapeutics, Inc.（DNTH.US）公布财报，公告显示公司2025财年第一财季净利润为-29.51百万美元，同比减少114.62%；其中营业收入为1.16百万美元，同比增加32.72%，每股基本收益为-0.82美元。从资产负债表来看，Dianthus Therapeutics, Inc.（DNTH.US）总负债19.97百万美元，其中短期债务226000.00美元，资产负债比为0.18，流动比率为0.16。机构评级：截至2025年5月19日，当前有10家机构对Dianthus Therapeutics, Inc.目标价做出预测，其中目标均价为51.40美元，其中最低目标价为34.00美元，最高目标价为84.00美元。公司简介：Dianthus Therapeutics Inc 是一家临床阶段的生物技术公司，致力于设计和提供新型单克隆抗体，与现有的补体疗法相比，其选择性和效力更高。该公司专注于为患有严重自身免疫和炎症性疾病的患者开发下一代补体疗法。该公司由一支经验丰富的生物技术和制药高管团队组成。该公司的产品线包括 DNTH103 一种皮下活性 C1s 抗体。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2536594430","isCrawlerRequest":true}